RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Model programs addressing perinatal drug exposure and human immunodeficiency virus infection: Integrating women's and children's needs
Breitbart, V., Chavkin, W., Layton, C., & Wise, P. (2004). Model programs addressing perinatal drug exposure and human immunodeficiency virus infection: Integrating women's and children's needs. Bulletin of the New York Academy of Medicine, 71(2), 236-251. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359281/
Many of the efforts to address perinatal drug exposure and human immunodeficiency virus infection have been influenced by a perspective of conflict between the interests of mother and infant. This article highlights several programs that integrate women's and children's services while dealing with these health issues. It discusses the challenges encountered by these programs, such as funding restrictions, institutional barriers, professional attitudes, regulatory constraints, and local political issues. It presents strategies for overcoming these barriers including the creative coordination of funding streams, innovative relationships with child protective agencies, effective collaboration with other agencies, and advocacy on behalf of clients and programs, and makes recommendations for certain policy changes, which could foster the development of programs that serve women and children together.